Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
Sun, 07/28/19 - 11:48 pm
Tags:
biotech, earnings, Immunic, Alkermes, Conatus, Aevi Genomic, Tricida, Curis, Ultragenyx, Leap Therapeutics, Cidara Therapeutics, Akcea, Spark Therapeutics, Eli Lilly, AnaptysBio, clinical trials
In a first, Lilly's ready-to-use rescue hypoglycemia powder wins US approval
Endpoints
Thu, 07/25/19 - 10:40 am
Tags:
Eli Lilly, FDA, hypoglycemia, Baqsimi
These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger
Investors Business Daily
Fri, 07/19/19 - 10:44 am
Tags:
Bristol-Myers Squibb, Celgene, M&A, Otezla, Gilead Sciences, Amgen, Regeneron, Eli Lilly, JNJ
Emgality-maker Lilly courts payers with new migraine ER data
Fierce Pharma
Fri, 07/12/19 - 12:22 pm
Tags:
Eli Lilly, Emgality, cluster headache, migraines, Amgen, Novartis, Teva Pharmaceutical, ER
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs
Xconomy
Thu, 07/11/19 - 11:15 pm
Tags:
Alzheimer's disease, BACE inhibitors, Merck, Eli Lilly, AstraZeneca, Amgen, Novartis, Biogen Eisai
Bayer floats animal health merger with Lilly spinoff Elanco: report
Fierce Pharma
Tue, 07/9/19 - 06:47 pm
Tags:
Bayer, animal health, Elanco, Eli Lilly, M&A
Array, Pierre Fabre bowel cancer therapy ‘could replace chemo’
Pharmaforum
Mon, 07/8/19 - 09:48 am
Tags:
Braftovi, Array Biopharma, Pierre Fabre, Eli Lilly, Mektovi, Erbitux, colorectal cancer, clinical trials
Lilly's Study on Higher Doses of Trulicity Meets Endpoint
Yahoo/Zacks.com
Thu, 06/27/19 - 06:43 pm
Tags:
Eli Lilly, clinical trials, type 2 diabetes, Trulicity
FDA fast-tracks BI, Lilly's Jardiance in chronic heart failure
Fierce Pharma
Wed, 06/26/19 - 04:59 pm
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, chronic heart failure, fast track
Lilly enlists patients to raise cluster headache awareness after Emgality scores second nod
Fierce Pharma
Wed, 06/26/19 - 04:56 pm
Tags:
Eli Lilly, Emgality, cluster headaches
Can A Drug That Delays The Onset Of Type 1 Diabetes Be A Success?
Forbes
Tue, 06/25/19 - 07:23 pm
Tags:
type 1 diabetes, Eli Lilly, teplizumab
Amgen, Lilly, Merck sue HHS to block price disclosures in DTC ads
BioCentury
Fri, 06/14/19 - 06:26 pm
Tags:
HHS, DTC ads, television ads, Merck, Eli Lilly, Amgen
Lilly’s Taltz scrapes win against Humira in psoriatic arthritis
Pharmaforum
Fri, 06/14/19 - 06:22 pm
Tags:
Eli Lilly, Taltz, AbbVie, Humira, psoriatic arthritis
House progressives challenge drugmakers to come back to Capitol Hill
Stat
Wed, 06/12/19 - 06:52 pm
Tags:
Democrats, drug pricing, Pfizer, Merck, Eli Lilly, Gilead Sciences, Mylan, Mallinckrodt
Look here, FDA: Eli Lilly touts Olumiant safety data for unapproved high dose
Fierce Pharma
Wed, 06/12/19 - 06:43 pm
Tags:
Eli Lilly, Incyte, olumiant, safety data, Humira, rheumatoid arthritis
Eli Lilly's Taltz touts long-term clear skin data after unimpressive first-quarter sales
Fierce Pharma
Tue, 06/11/19 - 06:00 pm
Tags:
Eli Lilly, Taltz, psoriasis
ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study
Fierce Pharma
Tue, 06/11/19 - 12:06 pm
Tags:
Eli Lilly, Boehringer Ingelheim, ADA, diabetes, Tradjenta
Lilly plans phase 2b NASH trial of dual GIP, GLP-1 agonist
Fierce Biotech
Mon, 06/10/19 - 09:39 am
Tags:
Eli Lilly, NASH, tirzepatide, clinial trials, ADA, type 2 diabetes
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
Fierce Pharma
Mon, 06/10/19 - 09:27 am
Tags:
Eli Lilly, ADA, diabetes, heart attack, stroke, Trulicity, Novo Nordisk, semaglutide
Eli Lilly throws SCOTUS hail mary in Cialis patent infringement fight
Fierce Pharma
Fri, 06/7/19 - 12:04 pm
Tags:
Eli Lilly, Cialis, patents, Patent Infringement, benign prostatic hyperplasia, Supreme Court

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.